Telix Pharmaceuticals Financial Ratios for Analysis 2023-2025 | TLX

Fifteen years of historical annual and quarterly financial ratios and margins for Telix Pharmaceuticals (TLX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20242023
2.781.41
0.500.10
1.020.12
65.0862.56
10.493.15
10.493.15
11.514.49
7.160.61
6.371.04
0.521.24
7.1710.87
5.627.76
64.9947.05
8.793.50
32.8213.28
3.291.28
4.423.16
1.120.31
0.080.05
0.050.03

Quarterly Data

Metric Name